GLY-230

N/A

Report date: 2022/11/25 16:34:12
NME

Base Information

Drug NameGLY-230
Drug Alias NameGLY-230EXO-230
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdvanced glycation end product inhibitors
TargetsAdvanced glycation end product
Therapy Area/IndicationsDiabetes MellitusDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlycadia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycadia Inc
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusDiabetic Nephropathies

Other Information

ATC CodeN/A
Related LinksN/A